T. Rowe Price Investment Management, Inc. Sarepta Therapeutics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,956,583 shares of SRPT stock, worth $201 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,956,583
Previous 1,946,240
0.53%
Holding current value
$201 Million
Previous $243 Million
2.12%
% of portfolio
0.15%
Previous 0.15%
Shares
6 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.06 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$935 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$895 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$445 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$419 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.01B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...